Union Bancaire Privee UBP SA bought a new stake in Xylem Inc. (NYSE:XYL - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 29,120 shares of the industrial products company's stock, valued at approximately $3,395,000.
A number of other large investors have also added to or reduced their stakes in XYL. Public Sector Pension Investment Board boosted its position in shares of Xylem by 77.3% in the 2nd quarter. Public Sector Pension Investment Board now owns 9,410 shares of the industrial products company's stock worth $1,276,000 after purchasing an additional 4,103 shares in the last quarter. AQR Capital Management LLC boosted its holdings in Xylem by 38.2% in the second quarter. AQR Capital Management LLC now owns 28,887 shares of the industrial products company's stock worth $3,918,000 after acquiring an additional 7,981 shares in the last quarter. Daymark Wealth Partners LLC boosted its holdings in Xylem by 32.1% in the second quarter. Daymark Wealth Partners LLC now owns 2,802 shares of the industrial products company's stock worth $380,000 after acquiring an additional 681 shares in the last quarter. MBB Public Markets I LLC purchased a new stake in shares of Xylem during the second quarter worth about $2,307,000. Finally, The Manufacturers Life Insurance Company raised its position in shares of Xylem by 0.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 153,978 shares of the industrial products company's stock valued at $20,885,000 after purchasing an additional 844 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.
Xylem Stock Performance
Shares of XYL traded up $0.59 during trading hours on Monday, hitting $122.16. The stock had a trading volume of 885,174 shares, compared to its average volume of 1,230,367. The firm has a 50-day moving average price of $120.87 and a 200 day moving average price of $128.21. Xylem Inc. has a fifty-two week low of $111.88 and a fifty-two week high of $146.08. The firm has a market capitalization of $29.68 billion, a price-to-earnings ratio of 35.72, a PEG ratio of 2.05 and a beta of 1.06. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96.
Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.11. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The business had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.17 billion. During the same period in the prior year, the company posted $0.99 EPS. The company's revenue for the quarter was up .2% on a year-over-year basis. As a group, research analysts anticipate that Xylem Inc. will post 4.23 EPS for the current year.
Xylem Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th were given a dividend of $0.36 per share. The ex-dividend date was Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.18%. Xylem's dividend payout ratio (DPR) is 42.11%.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on the stock. Stifel Nicolaus cut their price target on shares of Xylem from $166.00 to $150.00 and set a "buy" rating on the stock in a research note on Friday. Royal Bank of Canada reduced their target price on Xylem from $163.00 to $162.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. Citigroup dropped their price target on Xylem from $148.00 to $147.00 and set a "buy" rating on the stock in a research note on Monday, January 13th. Robert W. Baird decreased their target price on Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Finally, Wolfe Research reiterated a "peer perform" rating on shares of Xylem in a research report on Thursday, December 12th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $150.50.
Check Out Our Latest Analysis on XYL
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.